Table 2 Demographics between unresectable and successful groups
Variables | Unresectable (n = 4) | Successful (n = 27) | P value |
|---|---|---|---|
Age (mean) | 49 (SD = 5.6) | 49 (SD = 2.6) | 0.97 |
Gender (female) | 25% (1/4) | 63% (17/27) | 0.28 |
Race | 0.21 | ||
Chinese | 50%(2/4) | 81.5% (22/27) | |
Malay | 0% (0/4) | 0% (0/27) | |
Indian | 0% (0/4) | 0% (0/27) | |
Others | 50% (2/4) | 18.5% (5/27) | |
ECOG | 0.55 | ||
0 | 75% (3/4) | 59% (16/27) | |
1 | 25% (1/4) | 41% (11/27) | |
Overall comorbidity | |||
Cardiovascular | 25% (1/4) | 30% (8/27) | 0.85 |
Pulmonary | 100% (4/4) | 11% (3/27) | 0.78 |
Diabetes mellitus | 0% (0/4) | 19% (5/27) | 0.35 |
Primary tumour location | 0.50 | ||
Right-sided | 75% (3/4) | 44% (12/27) | |
Left-sided | 25% (!/4) | 48% (13/27) | |
Rectal | 0% (0/4) | 7% (2/27) | |
Histology | 0.00* | ||
Signet ring cell | 50% (2/4) | 0% (0/27) | |
Mucinous | 50% (2/4) | 26% (7/27) | |
Adenocarcinoma | |||
Well differentiated | 0% (0/4) | 7% (2/27) | |
Moderate differentiated | 0% (0/4) | 59% (16/27) | |
Poor differentiated | 0% (0/4) | 7% (2/27) | |
PCI score (mean) | 24 (SD = 2.6) | 10 (SD = 1.1) | 0.00* |
Completeness of cytoreduction | NA | ||
CC-0 | NA | 41% (11/27) | |
CC-1 | NA | 52% (14/27) | |
CC-2 | NA | 7% (2/27) | |